Asherson's disease is a rare autoimmune disorder. It affects the anticoagulation mechanism of blood. The exact cause of the disease is unknown but it may be due to antiphospholipid (APL) syndrome, hereditary, and gene transformation. This disease may affect all organs in the human body. There is no cure for the disease and no exact medicine has been identified. Supportive treatment is given to promote the betterment of the individual with Asherson's disease.
Asherson's syndrome [online]. National Organizations for Rare Disorders. Available at: https://rarediseases.org/rare-diseases/ashersons-syndrome/.
Cervera R, Asherson RA. Catastrophic antiphospholipid (Asherson's) syndrome. British Journal of Hospital Medicine 2019;69(7):384–387. DOI: https://doi.org/10.12968/hmed.2008.69.7.30413.
Cervera R, Font J, Gómez-Puerta JA, Espinosa G, Cucho M, Bucciarelli S, et al. Validation of the preliminary criteria for the classification of catastrophic antiphospholipid syndrome. Ann Rheum Dis 1998;77(3):195–207. DOI: 10.1097/00005792-199805000-00005.
Sciascia S, Lopez-Pedrera C, Roccatello D, Cuadrado MJ. Catastrophic antiphospholipid syndrome (CAPS). Best Practice and Research: Clinical Rheumatology 2012;26(4):535–541. DOI: 10.1016/j.berh.2012.07.005.
Cervera R, Font J, Gomez-Puerta JA, Espinosa G, Cucho M, Bucciarelli S, et al. Validation of the preliminary criteria for the classification of catastrophic antiphospholipid syndrome. Ann Rheum Dis 2005;64:1205–1209. DOI: 10.1136/ard.2004.025759.
Makatsariya A, Khizroeva J, Bitsadze V. Catastrophic antiphospholipid syndrome (Ronald Asherson syndrome) and obstetric pathology. Journal of Perinatal Medicine 2020;46(4):387–400. DOI: https://doi.org/10.1515/jpm-2017-0092.
Misita CP, Moll S. Antiphospholipid antibodies. Circulation 2005;112:e39–44. DOI: 10.1161/CIRCULATIONAHA.105.548495.
Ortel TL, Kitchens CS, Erkan D, Brandão LR, Hahn S, James AH, et al. Clinical causes and treatment of the thrombotic storm. Expert Review of Hematology 2020;5(6):653–659. DOI: 10.1586/ehm.12.56.